SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-11-034517
Filing Date
2011-02-14
Accepted
2011-02-14 12:44:30
Documents
1
Group Members
CLARUS VENTURES I LLCCLARUS VENTURES I MANAGEMENT, L.P.DENNIS HENNERKURT WHEELERMICHAEL STEINMETZNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAK

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 171220
  Complete submission text file 0001193125-11-034517.txt   173510
Mailing Address 12671 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12671 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 (858) 259-1165
ZOGENIX, INC. (Subject) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85795 | Film No.: 11604233
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences I, L.P. (Filed by) CIK: 0001431445 (see all company filings)

IRS No.: 203855540 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G